Humana Partners with Mark Cuban’s Cost Plus Drugs to Boost Distribution

Key Facts

Humana has officially announced a strategic pharmacy partnership with Mark Cuban's Cost Plus Drugs to enhance its pharmaceutical distribution capabilities. Under the terms of the agreement, Humana's CenterWell pharmacy unit will serve as a primary distributor for the platform. This collaboration aims to integrate advanced technology with Humana's extensive distribution infrastructure to streamline operations. The partnership is expected to lower medication costs and expand the reach of the Cost Plus Drugs platform to a broader patient base. By leveraging CenterWell’s logistics, both companies seek to disrupt traditional drug pricing models through increased transparency. This move underscores a growing trend of established healthcare giants partnering with innovative disruptors to optimize supply chain efficiency.